EDTXF
Spectral Medical Inc.
Set alert
0.74 USD +0.07 +11.20%
0.6983 Day range 0.6983
0.639 52-week range 1.10
- YTD
- -29.33%
- 1 year
- -33.18%
- Open
- 0.6983
- Prev close
- 0.661
- Mkt cap
- 215.76M
- Vol
- 1.00K
- Avg vol
- 9.95K
- EPS
- -0.09
- P/E
- 0.00
More statistics
- Low
- 0.6983
- High
- 0.6983
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 8, 2024 | Sep 1, 2024 | 0.00 | -0.03 | — | — |
| Aug 9, 2024 | Jun 1, 2024 | 0.00 | -0.01 | — | — |
| May 13, 2024 | Mar 1, 2024 | 0.00 | -0.01 | — | — |
| Mar 28, 2024 | Dec 1, 2023 | 0.00 | -0.02 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | -0.01 | — | — |
| Aug 10, 2023 | Jun 1, 2023 | 0.00 | -0.01 | — | — |
News
- Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX
- Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders
- Spectral Medical Inc. (EDT:CA) Shareholder/Analyst Call Transcript
- Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral's Tigris Trial
- Spectral Medical Announces PMA Submission to U.S. FDA for PMX
- Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update
- Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference
- Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update
- Spectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory Medicine
- Spectral Medical Provides Update on PMA Submission Timing for PMX-20R
Your note
Sign in to keep a note on EDTXF — it syncs with the Stock Master app.